KS
Kumari Sangita Singh
About Kumari Sangita Singh
Data last updated:
Kumari Sangita Singh is a Director at Medimount Pharmaceuticals Private Limited (since 2019). The company operates in Chemicals. Medimount Pharmaceuticals Private Limited reported revenue of ₹15 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medimount Pharmaceuticals Private Limited U24230MH2019PTC322145 | Director | 05 Mar 2019 | 2019 | ₹15 Lakh (FY 2023) | Active |
Board colleagues of Kumari Sangita Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rinki Singh | 08380629 | Medimount Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumari Sangita Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumari Sangita Singh
Kumari Sangita Singh currently holds 1 directorship: Medimount Pharmaceuticals Private Limited (Director, since 05 Mar 2019, revenue ₹15 Lakh (FY 2023)).
Kumari Sangita Singh was first appointed on 05 Mar 2019 as Director at Medimount Pharmaceuticals Private Limited.
The current boards of Kumari Sangita Singh's companies include Rinki Singh (Medimount Pharmaceuticals Private Limited).